Home > Insider Trading > Filing (0000908834-23-000047)

Filing Details

Accession Number:: 0000908834-23-000047
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-26 13:13:30
Reporting Period:: 2020-02-11

Accepted Time:: 2023-05-26 13:13:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
811240	Biolase Inc	BIOL	Dental Equipment & Supplies (3843)	870442441

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1512977	Foundation Education Schuler	100 N. Field Drive Suite 360 Lake Forest IL 60045		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-11	1,307,931	$0.61	10,936,444	No	4	P	Direct
Common Stock	Disposition	2020-06-08	1,847,649	$0.55	9,088,795	No	4	S	Direct
Common Stock	Disposition	2020-06-09	2,137,559	$0.54	6,951,236	No	4	S	Direct
Common Stock	Disposition	2020-06-10	1,733,836	$0.55	5,217,400	No	4	S	Direct
Common Stock	Acquisiton	2020-07-28	3,745,000	$0.40	8,962,400	No	4	C	Direct
Common Stock	Disposition	2020-11-24	71,100	$0.30	8,891,300	No	4	S	Direct
Common Stock	Disposition	2020-11-25	203,057	$0.29	8,688,243	No	4	S	Direct
Common Stock	Disposition	2020-11-30	1,115,000	$0.30	7,573,243	No	4	S	Direct
Common Stock	Disposition	2020-12-04	1,200,000	$0.30	6,373,243	No	4	S	Direct
Common Stock	Disposition	2020-12-16	90,575	$0.28	6,282,668	No	4	S	Direct
Common Stock	Disposition	2020-12-17	572,671	$0.28	5,709,997	No	4	S	Direct
Common Stock	Disposition	2020-12-18	187,774	$0.28	5,522,223	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	C	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series F Convertible Preferred Stock	Acquisiton	2020-07-22	1,498	$0.00	3,745,000	$0.40
Common Stock	Warrants	Acquisiton	2020-07-22	3,745,000	$0.00	3,745,000	$0.40
Common Stock	Series F Convertible Preferred Stock	Disposition	2020-07-28	1,498	$0.00	3,745,000	$0.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,498	2020-07-22		No	4	A	Direct
3,745,000	2020-07-22	2025-07-22	No	4	A	Direct
0	2020-07-22		No	4	C	Direct

Footnotes

This late filing is due to inadvertent administrative error.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5399 and $0.5643, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5430 and $0.5601, inclusive.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5485 and $0.5656, inclusive.
In connection with a public offering by the Issuer, on July 22, 2020, the Reporting Person acquired (i) 1,498 shares of Series F Convertible Preferred Stock, each of which is convertible into 2,500 shares of Common Stock, for a total of up to 3,745,000 shares of Common Stock, and (ii) 3,745,000 Warrants, each of which is exercisable to purchase one share of Common Stock, for a total of up to 3,745,000 shares of Common Stock, for an aggregate purchase price of $1,500,000.
Each share of Series F Convertible Preferred Stock is convertible at the Issuer's option at any time on or after July 22, 2021 or at the option of the Reporting Person at any time.
On July 28, 2020, the Reporting Person converted 1,498 shares of Series F Convertible Preferred Stock into 3,745,000 shares of Common Stock.